Ensign Peak Advisors’s SpringWorks Therapeutics SWTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19,241	Closed	-$849K	–	1719
2025 Q1	$849K	Buy	19,241 +200	+1%	+$9.21K	﹤0.01%	1338
2024 Q4	$688K	Sell	19,041 -145,903	-88%	-$5.1M	﹤0.01%	1505
2024 Q3	$5.28M	Buy	164,944 +200	+0.1%	+$7.47K	0.01%	610
2024 Q2	$6.21M	Buy	164,744 +62,953	+62%	+$2.65M	0.01%	573
2024 Q1	$5.01M	Buy	101,791 +81,791	+409%	+$3.78M	0.01%	630
2023 Q4	$730K	Buy	+20,000	New	+$522K	﹤0.01%	1542
2022 Q4	–	Sell	-5,220	Closed	-$149K	–	2176
2022 Q3	$149K	Sell	5,220 -70,499	-93%	-$2.02M	﹤0.01%	1980
2022 Q2	$1.86M	Sell	75,719 -38,471	-34%	-$1.41M	﹤0.01%	828
2022 Q1	$6.45M	Buy	114,190 +11,410	+11%	+$653K	0.01%	521
2021 Q4	$6.37M	Buy	102,780 +20,619	+25%	+$1.36M	0.01%	595
2021 Q3	$5.21M	Buy	82,161 +17,527	+27%	+$1.35M	0.01%	645
2021 Q2	$5.33M	Buy	64,634 +20,408	+46%	+$1.55M	0.01%	630
2021 Q1	$3.25M	Buy	44,226 +18,200	+70%	+$1.43M	0.01%	822
2020 Q4	$1.89M	Hold	26,026	–	–	﹤0.01%	1096
2020 Q3	$1.24M	Buy	26,026 +16,623	+177%	+$708K	﹤0.01%	1213
2020 Q2	$395K	Hold	9,403	–	–	﹤0.01%	1505
2020 Q1	$254K	Buy	+9,403	New	+$307K	﹤0.01%	1503